[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100603093":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":36,"locations":46,"responsibleParty":89,"collaborators":93,"id":97,"slug":98,"hasResults":99,"nctId":100,"briefTitle":101,"officialTitle":102,"acronym":103,"eligibilityCriteria":104,"healthyVolunteers":99,"sex":105,"minAge":106,"maxAge":26,"enrollmentInfo":107,"targetDuration":26,"studyType":110,"phases":111,"briefSummary":113,"conditions":114,"keywords":117,"overallStatus":49,"whyStopped":26,"lastUpdateSubmitDate":120,"lastUpdatePostDateStruct":121,"startDateStruct":124,"completionDateStruct":125,"leadSponsor":127,"locationsCount":128},{"fullName":5,"class":6},"University Hospital, Basel, Switzerland","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Acupuncture:","EXPERIMENTAL","8 sessions of acupuncture treatment, once a week",[13],"Procedure: Acupuncture",{"label":15,"type":16,"description":17,"interventionNames":18},"Wait-listed control group","PLACEBO_COMPARATOR","Supportive care according to local standards will be given which may also include face-to-face psychosocial support or the participation of support groups. 8 weeks after the assessment T1 and upon completion of assessment T2, participants will receive access to 8 sessions of weekly acupuncture treatment.",[19],"Other: Standard supportive care",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"PROCEDURE","Acupuncture","8 sessions of acupuncture treatment (body and auricular acupuncture) will be given once a week after randomization.",[9],null,{"type":6,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Standard supportive care","Supportive care according to local standards will be given which may also include face-to-face psychosocial support or the participation of support groups",[15],[32],{"name":33,"affiliation":34,"role":35},"Viola Heinzelmann-Schwarz, Prof.MD","University Hospital of Basel","STUDY_CHAIR",[37,42],{"name":38,"role":39,"phone":40,"phoneExt":26,"email":41},"Isabell Xiang Ge, MD","CONTACT","+41 61 265 85885","isabellxiang.ge@usb.ch",{"name":43,"role":39,"phone":44,"phoneExt":26,"email":45},"Christian Kurzeder, Prof.MD","+41 61 32 87990","christian.kurzeder@usb.ch",[47,62,76],{"facility":48,"status":49,"city":50,"state":26,"zip":51,"country":52,"countryCode":53,"cosmosGeoPoint":54,"geoPoint":59,"contacts":60},"University Hospital Basel","RECRUITING","Basel","4031","Switzerland","CH",{"type":55,"coordinates":56},"Point",[57,58],7.57327,47.55839,{"lat":58,"lon":57},[61],{"name":38,"role":39,"phone":40,"phoneExt":26,"email":41},{"facility":63,"status":64,"city":65,"state":26,"zip":26,"country":52,"countryCode":53,"cosmosGeoPoint":66,"geoPoint":70,"contacts":71},"Gesundheitszentrum Fricktal AG Frauenklinik","NOT_YET_RECRUITING","Rheinfelden",{"type":55,"coordinates":67},[68,69],7.79403,47.55437,{"lat":69,"lon":68},[72],{"name":73,"role":39,"phone":74,"phoneExt":26,"email":75},"Dr. Rosa Jochim-Maier","+41 61 835 62 20","frauenklinik@gzf.ch",{"facility":77,"status":49,"city":78,"state":26,"zip":26,"country":52,"countryCode":53,"cosmosGeoPoint":79,"geoPoint":83,"contacts":84},"Onkologie- & Hämatologiezentrums, Spital STS AG Thun","Thun",{"type":55,"coordinates":80},[81,82],7.62166,46.75118,{"lat":82,"lon":81},[85],{"name":86,"role":39,"phone":87,"phoneExt":26,"email":88},"Nurgül Usluoglu, MD","+41 58 636 26 45","studienkoordinationonkologie@spitalstsag.ch",{"type":90,"investigatorFullName":91,"investigatorTitle":92,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"SPONSOR_INVESTIGATOR","Isabell Xiang Ge","Dr. med.",[94],{"name":95,"class":96},"Swiss GO Trial Group","NETWORK","100603093","stress-reduction-through-acupuncture-100603093",false,"NCT07132034","Stress Reduction Through Acupuncture","Study Protocol: Stress Reduction in Breast Cancer Patients During Transition Into Survivorship Using Acupuncture - a Randomized Wait-list-controlled Intervention Study","STREAK","Inclusion criteria:\n\n* Patients with localized breast cancer having completed primary therapy (operation +\u002F- chemotherapy +\u002F- radiotherapy) in the last 6 months - Distress Thermometer ≥ 5 - Age ≥ 18 years - Signed informed consent for participation of the trial\n* Prior cancer is allowed\n* Prior treatment - including chemotherapy - for a prior malignant tumor (including breast cancer) is allowed\n* Concomitant participation in an experimental therapeutic drug trial is allowed\n* Ongoing or planned Anti-her2\u002Fneu, immune checkpoint inhibitor, antihormonal and CDK4\u002F6 inhibitor therapy or other adjuvant treatment scheduled for \\> 3 months during study period is allowed\n* Use of other complementary methods (including mistletoe) is allowed.\n\nExclusion criteria:\n\n* Patients with language or cognitive deficits (including impaired consciousness) that are incompatible with the participation in the study\n* Severe physical or psychiatric comorbidity that prevents a patient from participating in the study\n* Patients incapable of giving consent\n* Pregnancy","FEMALE","18 Years",{"count":108,"type":109},112,"ESTIMATED","INTERVENTIONAL",[112],"NA","This randomized controlled trial evaluates whether eight weeks of weekly acupuncture can reduce psychological distress in breast cancer patients who have recently completed primary therapy compared to standard-of-care wait-list control.",[23,115,116],"Breast Cancer","Survivorship",[118,23,115,116,119],"Integrative Oncology","Distress","2026-07-07",{"date":122,"type":123},"2026-07-09","ACTUAL",{"date":120,"type":123},{"date":126,"type":109},"2029-09",{"name":91,"class":6},3]